상단으로
Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Seegene Participates in 23rd World Congress on Controversies in Obstetrics, Gynecology & Infertility
Mar 21, 2016
?
From March 21~23, Seegene participated in the 23rd World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) in Melbourne, Australia.
?
Held twice a year, COGI is a representative global OB-GYN conference with presentations and discussions on the latest research, information, and treatment methods for obstetrics, gynecology, and infertility/reproductive medicine.
?
Through the congress, Seegene had the opportunity to meet with world-class HPV experts and Australian medical experts and obtain a better grasp of the current status and diagnosis system of HPV infection management. It also garnered information on infection-related health projects being conducted in Australia. These insights will be valuable for Seegene’s entry into the Australian cervical cancer market.
?
Seegene introduced two products at this year’s congress: the Anyplex™ II HPV28 Detection, which tests for all major HPVs that cause ailments such as cervical cancer or genital warts; and the Anyplex™ II HPV HR Detection, which tests for 14 types of high-risk HPVs. The Anyplex™ II HPV HR Detection was of particular interest to participants due to its confirmation (through clinical evaluations conducted according to international guidelines) as a product appropriate for screening for cervical cancer.
?
Seegene is planning to enter Australia’s molecular diagnosis market with its Allplex Respiratory and Gastrointestinal Panel Assays, both of which have received TGA (Therapeutic Goods Administration; Australia’s version of the US’ FDA) certification. By obtaining additional certification for its HPV diagnosis products, Seegene hopes to secure more customers in the near future.